A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
3D maps for Airbnb hosts, Toxicity detection in organisations by Microsoft, & more
Emotion tracking from Amazon, e-sports live streaming from Disney & more